← Leaderboards
Paul E Monahan
University Of North Carolina Chapel Hill
$4,569,284
Attributed
$4,569,284
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $568.2K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
CDC$2,661,305 · 2
NIH$1,907,979 · 4
By mechanism
U01$2,661,305 · 1
P01$1,491,451 · 2
K08$416,526 · 1
P30$2 · 1
U27$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Darrel W Stafford$14,989,135
- Ronald J Falk$26,386,981
- Harold R Roberts$2,228,805
- Mark T Heise$26,876,746
- Sohini Sengupta$507,887
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyGene ExpressionNeutralizing AntibodyHemophilia BVirusComplementResponseInstitutionVectorSafetyGenesAdeno-Associated Viral VectorDoseGene DeliveryHemophilia AEvaluationViral VectorChondrocytesAdjuvantChronicCodon NucleotidesChildhoodDependovirusDeveloped Countries
Grant awards (25)
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$149,913
P01 · FY2017 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$149,911
P01 · FY2017 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$152,001
P01 · FY2016 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$151,999
P01 · FY2016 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$149,529
P01 · FY2015 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$149,528
P01 · FY2015 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$150,087
P01 · FY2014 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$150,083
P01 · FY2014 · HL · contact PI
INTRAARTICULAR AAV TO CIRCUMVENT SYSTEMIC NEUTRALIZATION$288,400
P01 · FY2013 · HL · contact PI
Prevention of the Complications of Bleeding Disorder Through HTCs$456,667
U01 · FY2010 · DD · contact PI
Prevention of the Complications of Bleeding Disorder Through HTCs$534,113
U01 · FY2009 · DD · contact PI
Gene Transfer Clinical Core Unit$2
P30 · FY2009 · DK · contact PI
Prevention of the Complications of Bleeding Disorder Through HTCs$534,113
U01 · FY2008 · DD · contact PI
Prevention of the Complications of Bleeding Disorder Through HTCs$568,206
U01 · FY2007 · DD · contact PI
Prevention of the Complications of Bleeding Disorder Through HTCs$568,206
U01 · FY2006 · DD · contact PI
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2005 · DD
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2004 · DD
AAV DIRECTED MUSCLE GENE THERAPY FOR HEMOPHILIA B$114,077
K08 · FY2003 · HL
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2003 · DD
AAV DIRECTED MUSCLE GENE THERAPY FOR HEMOPHILIA B$114,077
K08 · FY2002 · HL
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2002 · DD
AAV DIRECTED MUSCLE GENE THERAPY FOR HEMOPHILIA B$114,077
K08 · FY2001 · HL
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2001 · DD
AAV DIRECTED MUSCLE GENE THERAPY FOR HEMOPHILIA B$74,295
K08 · FY2000 · HL
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS$0
U27 · FY2000 · DD